| Entry |
|
|---|
| Name |
Insulin glulisine (genetical recombination) (JAN);
Insulin glulisine (USAN/INN);
Apidra (TN)
|
|---|
| Product |
|
|---|
| Formula |
C258H384N64O78S6
|
|---|
| Exact mass |
5818.6373
|
|---|
| Mol weight |
5822.5816
|
|---|
| Sequence |
(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr
Gln Leu Glu Asn Tyr Cys Asn (Disulfide bridge: 6-11)
(B chain) Phe Val Lys Gln His Leu Cys Gly Ser His Leu Val Glu Ala
Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Glu Thr
(Disulfide bridge: A7-B7; A20-B19) |
|---|
| Type |
Peptide |
|---|
| Activity |
|
|---|
| Remark |
Therapeutic category: ATC code: |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
CYP induction: CYP1A2 [HSA: 1544]
 |
|---|
| Structure map |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D04540 Insulin glulisine (genetical recombination) (JAN); Insulin glulisine (USAN/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AB Insulins and analogues for injection, fast-acting
A10AB06 Insulin glulisine
D04540 Insulin glulisine (genetical recombination) (JAN); Insulin glulisine (USAN/INN)
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Rapid-acting
Insulin glulisine
D04540 Insulin glulisine (genetical recombination) (JAN); Insulin glulisine (USAN/INN)
Target-based classification of drugs [BR:br08310]
Cytokine receptors
Receptor tyrosine kinase
RTK class II (Insulin receptor family)
insulin receptor [HSA:3643] [KO:K04527]
Insulin glulisine [ATC:A10AB06]
D04540 Insulin glulisine (genetical recombination) (JAN); Insulin glulisine (USAN/INN)
 |
|---|
| Other DBs |
|
|---|
